Skip to main content
. 2015 Mar 5;10:1819–1830. doi: 10.2147/IJN.S78895

Figure 2.

Figure 2

Effect of various nanoparticulated formulations on the aqueous solubility of fenofibrate.

Notes: Each value represents the mean ± SD (n=3): (a) fenofibrate powder, (b) PVP nanospheres, (c) HP-β-CD nanocorpuscles, and (d) gelatin nanocapsules. P<0.05 for each formulation compared to the drug powder.

Abbreviations: SD, standard deviation; PVP, polyvinylpyrrolidone; HP-β-CD, hydroxypropyl-β-cyclodextrin.